Interact to see
Advertisement
Advertisement
NUV vs RFMZ
NUV vs RFMZ Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
NUV vs. RFMZ commentary
Jul 27, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUV is a Hold and RFMZ is a Buy.
SUMMARIES
FUNDAMENTALS
Fundamentals
NUV has more net assets: 1.83B vs. RFMZ (335M). NUV has a higher annual dividend yield than RFMZ: NUV (2.068) vs RFMZ (-2.114). NUV was incepted earlier than RFMZ: NUV (38 years) vs RFMZ (4 years). NUV (0.47) has a lower expense ratio than RFMZ (4.27). RFMZ has a higher turnover NUV (21.00) vs NUV (21.00).
| NUV | RFMZ | NUV / RFMZ | |
| Gain YTD | 2.068 | -2.114 | -98% |
| Net Assets | 1.83B | 335M | 547% |
| Total Expense Ratio | 0.47 | 4.27 | 11% |
| Turnover | 21.00 | 53.00 | 40% |
| Yield | 4.22 | 2.03 | 208% |
| Fund Existence | 38 years | 4 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| NUV | RFMZ | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 70% | N/A |
| Stochastic ODDS (%) | 3 days ago 82% | 3 days ago 82% |
| Momentum ODDS (%) | 3 days ago 69% | 3 days ago 70% |
| MACD ODDS (%) | 3 days ago 76% | 3 days ago 65% |
| TrendWeek ODDS (%) | 3 days ago 70% | 3 days ago 73% |
| TrendMonth ODDS (%) | 3 days ago 74% | 3 days ago 86% |
| Advances ODDS (%) | 3 days ago 76% | 3 days ago 84% |
| Declines ODDS (%) | 5 days ago 76% | 17 days ago 73% |
| BollingerBands ODDS (%) | 3 days ago 83% | 3 days ago 83% |
| Aroon ODDS (%) | 3 days ago 70% | 3 days ago 82% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ASVIX | 10.10 | 0.06 | +0.60% |
| American Century Small Cap Value Inv | |||
| VITSX | 152.68 | 0.67 | +0.44% |
| Vanguard Total Stock Market Idx I | |||
| GCLLX | 17.21 | 0.06 | +0.35% |
| Goldman Sachs Enhanced U.S. Equity C | |||
| VECRX | 22.33 | 0.07 | +0.31% |
| Virtus KAR Equity Income R6 | |||
| FBTTX | 25.58 | N/A | N/A |
| Fidelity Advisor Biotechnology M | |||